Skip to main
WELL
WELL logo

Welltower (WELL) Stock Forecast & Price Target

Welltower (WELL) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 64%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Welltower's diversified healthcare portfolio includes 2,391 in-place properties across various sectors, with over 100 properties in Canada and the United Kingdom, positioning the company well for further investment in mature healthcare systems. The company has demonstrated substantial financial growth, with projected FY24 revenue and EBITDA increases of 30% year-over-year and 22% year-over-year, respectively, driven by strong performance in Canadian operations and organic growth initiatives. Furthermore, Welltower's improved ESG ratings, moving from the bottom 10th percentile to the top 70th percentile, reflect a positive shift in corporate sustainability, which may enhance investor confidence and long-term value.

Bears say

Welltower's fundamental challenges include the difficulty of successfully integrating recent acquisitions, which, if not addressed, could lead to diminished EBITDA margins amid escalating competition in higher-growth segments. The company reported a disappointing EBITDA loss of $3.7 million, significantly falling short of both consensus estimates and guidance expectations, ultimately resulting in a revenue reduction of $56.6 million for 2024. Furthermore, the EBITDA guidance for 2024, excluding deferred revenue, was lower than anticipated by market analysts, indicating persistent operational and financial concerns that could adversely affect future performance.

Welltower (WELL) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 64% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Welltower and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Welltower (WELL) Forecast

Analysts have given Welltower (WELL) a Buy based on their latest research and market trends.

According to 11 analysts, Welltower (WELL) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.91, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.91, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Welltower (WELL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.